131 related articles for article (PubMed ID: 10049064)
1. Theophylline-induced B-CLL apoptosis is partly dependent on cyclic AMP production but independent of CD38 expression and endogenous IL-10 production.
Mentz F; Merle-Beral H; Dalloul AH
Leukemia; 1999 Jan; 13(1):78-84. PubMed ID: 10049064
[TBL] [Abstract][Full Text] [Related]
2. Type 4 cyclic adenosine monophosphate phosphodiesterase as a therapeutic target in chronic lymphocytic leukemia.
Kim DH; Lerner A
Blood; 1998 Oct; 92(7):2484-94. PubMed ID: 9746789
[TBL] [Abstract][Full Text] [Related]
3. Theophylline, a new inducer of apoptosis in B-CLL: role of cyclic nucleotides.
Mentz F; Merle-Beral H; Ouaaz F; Binet JL
Br J Haematol; 1995 Aug; 90(4):957-9. PubMed ID: 7669680
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis or plasma cell differentiation of CD38-positive B-chronic lymphocytic leukemia cells induced by cross-linking of surface IgM or IgD.
Zupo S; Massara R; Dono M; Rossi E; Malavasi F; Cosulich ME; Ferrarini M
Blood; 2000 Feb; 95(4):1199-206. PubMed ID: 10666191
[TBL] [Abstract][Full Text] [Related]
5. CD38 expression correlates with adverse biological features and predicts poor clinical outcome in B-cell chronic lymphocytic leukemia.
D'Arena G; Musto P; Cascavilla N; Dell'Olio M; Di Renzo N; Perla G; Savino L; Carotenuto M
Leuk Lymphoma; 2001 Jun; 42(1-2):109-14. PubMed ID: 11699197
[TBL] [Abstract][Full Text] [Related]
6. Different effect of prostaglandin E2 on B-cell activation by two distinct B-cell differentiation factors, B151-TRF1/IL-5 and B151-TRF2: selective inhibition of B151-TRF2-induced antibody response through increases in intracellular cyclic AMP levels.
Ishihara K; Ono S; Takahama Y; Hirayama F; Hirano H; Itoh K; Dobashi K; Murakami S; Katoh Y; Yamaguchi M
Immunology; 1989 Oct; 68(2):154-62. PubMed ID: 2553585
[TBL] [Abstract][Full Text] [Related]
7. Effect of PGE2 and of agents that raise cAMP levels on macrophage activation induced by IFN-gamma and TNF-alpha.
Mauël J; Ransijn A; Corradin SB; Buchmüller-Rouiller Y
J Leukoc Biol; 1995 Aug; 58(2):217-24. PubMed ID: 7543922
[TBL] [Abstract][Full Text] [Related]
8. PDE7A is expressed in human B-lymphocytes and is up-regulated by elevation of intracellular cAMP.
Lee R; Wolda S; Moon E; Esselstyn J; Hertel C; Lerner A
Cell Signal; 2002 Mar; 14(3):277-84. PubMed ID: 11812656
[TBL] [Abstract][Full Text] [Related]
9. Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemia.
Jelinek DF; Tschumper RC; Geyer SM; Bone ND; Dewald GW; Hanson CA; Stenson MJ; Witzig TE; Tefferi A; Kay NE
Br J Haematol; 2001 Dec; 115(4):854-61. PubMed ID: 11843819
[TBL] [Abstract][Full Text] [Related]
10. CD38 expression distinguishes two groups of B-cell chronic lymphocytic leukemias with different responses to anti-IgM antibodies and propensity to apoptosis.
Zupo S; Isnardi L; Megna M; Massara R; Malavasi F; Dono M; Cosulich E; Ferrarini M
Blood; 1996 Aug; 88(4):1365-74. PubMed ID: 8695855
[TBL] [Abstract][Full Text] [Related]
11. Induction of CD38/NADase and its monoclonal antibody-induced tyrosine phosphorylation in human leukemia cell lines.
Kontani K; Kukimonto I; Kanda Y; Inoue S; Kishimoto H; Hoshino S; Katada T
Biochem Biophys Res Commun; 1996 May; 222(2):466-71. PubMed ID: 8670228
[TBL] [Abstract][Full Text] [Related]
12. Peripheral blood CD38 expression predicts survival in B-cell chronic lymphocytic leukemia.
Morabito F; Mangiola M; Oliva B; Stelitano C; Callea V; Deaglio S; Iacopino P; Brugiatelli M; Malavasi F
Leuk Res; 2001 Nov; 25(11):927-32. PubMed ID: 11597727
[TBL] [Abstract][Full Text] [Related]
13. Immunoglobulin V genes and CD38 expression in CLL.
Hamblin TJ; Orchard JA; Gardiner A; Oscier DG; Davis Z; Stevenson FK
Blood; 2000 Apr; 95(7):2455-7. PubMed ID: 10787241
[No Abstract] [Full Text] [Related]
14. Theophylline synergizes with chlorambucil in inducing apoptosis of B-chronic lymphocytic leukemia cells.
Mentz F; Mossalayi MD; Ouaaz F; Baudet S; Issaly F; Ktorza S; Semichon M; Binet JL; Merle-Beral H
Blood; 1996 Sep; 88(6):2172-82. PubMed ID: 8822937
[TBL] [Abstract][Full Text] [Related]
15. Type 4 cAMP phosphodiesterase (PDE4) inhibitors augment glucocorticoid-mediated apoptosis in B cell chronic lymphocytic leukemia (B-CLL) in the absence of exogenous adenylyl cyclase stimulation.
Tiwari S; Dong H; Kim EJ; Weintraub L; Epstein PM; Lerner A
Biochem Pharmacol; 2005 Feb; 69(3):473-83. PubMed ID: 15652238
[TBL] [Abstract][Full Text] [Related]
16. IL-3 increases production of B lymphoid progenitors from human CD34+CD38- cells.
Crooks GM; Hao QL; Petersen D; Barsky LW; Bockstoce D
J Immunol; 2000 Sep; 165(5):2382-9. PubMed ID: 10946261
[TBL] [Abstract][Full Text] [Related]
17. TGF-beta 1 and cyclic AMP promote apoptosis in resting human B lymphocytes.
Lømo J; Blomhoff HK; Beiske K; Stokke T; Smeland EB
J Immunol; 1995 Feb; 154(4):1634-43. PubMed ID: 7836748
[TBL] [Abstract][Full Text] [Related]
18. Effects of forskolin on Kupffer cell production of interleukin-10 and tumor necrosis factor alpha differ from those of endogenous adenylyl cyclase activators: possible role for adenylyl cyclase 9.
Dahle MK; Myhre AE; Aasen AO; Wang JE
Infect Immun; 2005 Nov; 73(11):7290-6. PubMed ID: 16239525
[TBL] [Abstract][Full Text] [Related]
19. Role of prostaglandin-mediated cyclic AMP formation in protein kinase C-dependent secretion of atrial natriuretic peptide in rat cardiomyocytes.
Church DJ; Van der Bent V; Vallotton MB; Lang U
Biochem J; 1994 Oct; 303 ( Pt 1)(Pt 1):217-25. PubMed ID: 7945244
[TBL] [Abstract][Full Text] [Related]
20. Peripheral blood CD38 expression predicts time to progression in B-cell chronic lymphocytic leukemia after first-line therapy with high-dose chlorambucil.
Morabito F; Mangiola M; Stelitano C; Deaglio S; Callea V; Malavasi F
Haematologica; 2002 Feb; 87(2):217-8. PubMed ID: 11836173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
